GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($ 1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market.
Personal Fitness Trainer Directory
Trainers and Everything Fitness